Shree Baidyanath Ayurved Bhawan Pvt Ltd Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Shree Baidyanath Ayurved Bhawan Pvt Ltd Pharmaceutical Export Portfolio Dataset — 2 Products, $317.8K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Shree Baidyanath Ayurved Bhawan Pvt Ltd — Pharmaceutical Exporter Profile (2026) | 2 Products, $317.8K Trade | TransData Nexus

Shree Baidyanath Ayurved Bhawan Pvt Ltd

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $317.8K Total Trade · DGFT Verified

Shree Baidyanath Ayurved Bhawan Pvt Ltd is an Indian pharmaceutical exporter with a total trade value of $317.8K across 2 products in 1 therapeutic categories. Based on 180 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ayurvedic ($315.9K), Gutika ($2.0K), .

Shree Baidyanath Ayurved Bhawan Pvt Ltd — Export Portfolio & Destination Treemap

Shree Baidyanath Ayurved Bhawan Pvt Ltd pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Shree Baidyanath Ayurved Bhawan Pvt Ltd? — Company Overview & Market Position

Shree Baidyanath Ayurved Bhawan Pvt Ltd, commonly known as Baidyanath Ayurved, was established in 1917 by Vaidya Pandit Ram Narayan Sharma and Pandit Ram Dayal Joshi. The company is headquartered at 1 Gupta Lane, Kolkata, West Bengal, India. It operates as a private limited company, registered under the Corporate Identification Number (CIN) U24233WB1947PTC015374. The authorized capital is ₹20 million, with a paid-up capital of ₹3 million. As of the latest available data, the company employs approximately 1,700 individuals, including 150 marketing experts, 25 research experts, and 125 management professionals.

Baidyanath Ayurved specializes in the manufacturing and marketing of Ayurvedic products, offering over 700 formulations. These products are distributed across more than 100,000 retail outlets and cater to over 50,000 practitioners. The company's diverse product range includes herbal remedies, tonics, powders, tablets, oils, and syrups, all prepared using traditional Ayurvedic principles combined with modern research and manufacturing techniques. (baidyanath.co)

What Does Shree Baidyanath Ayurved Bhawan Pvt Ltd Export? — Product Portfolio Analysis

Top Products by Export Value

1Ayurvedic$315.9K

Product Portfolio — Top 2 by Export Value

Shree Baidyanath Ayurved Bhawan Pvt Ltd exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ayurvedic	Ayurvedic & Herbal Products	$315.9K	176	1.4%	15
2	Gutika	Ayurvedic & Herbal Products	$2.0K	4	1.6%	12

Shree Baidyanath Ayurved Bhawan Pvt Ltd exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $317.8K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Shree Baidyanath Ayurved Bhawan Pvt Ltd — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Baidyanath Ayurved operates state-of-the-art manufacturing facilities to produce its extensive range of Ayurvedic products. The primary manufacturing plant is located in Naini, Prayagraj, Uttar Pradesh, covering 37 acres. Established in the late 1960s, this facility is complemented by another plant in Greater Noida, Uttar Pradesh. These facilities are equipped with modern machinery and adhere to Good Manufacturing Practices (GMP) standards, ensuring the highest quality and efficacy of the products.

3Key Leadership

The leadership team at Baidyanath Ayurved comprises several key individuals:

Pramod Sharma: Managing Director since April 20, 1987.
Anurag Sharma: Managing Director since January 1, 2002.
Sureshkumar Ramnarayan Sharma: Managing Director since April 1, 1975.
Arvind Sharma: Director since December 13, 2006.
Abhinav Gaur: Director since July 30, 2013.

These leaders have been instrumental in steering the company towards growth and innovation in the Ayurvedic pharmaceutical sector.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Shree Baidyanath Ayurved Bhawan Pvt Ltd Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Baidyanath Ayurved's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly detailed in the available sources. The company's focus has primarily been on the Indian market and select international regions. For instance, Baidyanath Ayurved has established a significant distribution network within India, catering to a vast number of retail outlets and practitioners. (baidyanath.co) However, specific regulatory approvals or market access statuses in the aforementioned countries are not provided in the available information.

2Emerging Markets

Baidyanath Ayurved has made strategic inroads into emerging markets, particularly in Africa, Latin America, and Southeast Asia. The company's commitment to quality and authenticity has facilitated its expansion into these regions. While specific details regarding WHO prequalification or other certifications enabling access to these markets are not provided, Baidyanath Ayurved's longstanding reputation and adherence to international quality standards likely support its market penetration. (baidyanath.co)

3Geographic Strategy

Shree Baidyanath Ayurved Bhawan Pvt Ltd — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Baidyanath Ayurved's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history are not available in the provided sources. The company's primary focus has been on the Indian market and select international regions, with limited information on its activities in the U.S. market. For comprehensive FDA-related information, direct consultation with the FDA database or Baidyanath Ayurved's official communications would be necessary.

2WHO & EU GMP

The available information does not specify whether Baidyanath Ayurved holds WHO prequalification or EU GMP certificates. The company's manufacturing facilities adhere to GMP standards, ensuring product quality and safety. However, explicit certifications from WHO or the European Medicines Agency (EMA) are not detailed in the provided sources. For precise certification statuses, direct verification with Baidyanath Ayurved or the respective regulatory bodies is recommended.

3CDSCO & Indian Regulatory

Shree Baidyanath Ayurved Bhawan Pvt Ltd — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Baidyanath Ayurved operates in a competitive landscape with several key players in the Ayurvedic pharmaceutical sector. Top competitors include:

Dabur India Ltd.: A leading manufacturer of Ayurvedic products with a diverse portfolio.
Himalaya Drug Company: Known for its herbal healthcare products.
Patanjali Ayurved Ltd.: A rapidly growing company offering a wide range of Ayurvedic products.

While specific market share comparisons are not available, Baidyanath Ayurved's extensive product range and distribution network position it as a significant player in the market. The company's focus on quality and authenticity provides a competitive edge in the Ayurvedic pharmaceutical industry.

2Key Differentiators

Baidyanath Ayurved's key differentiators include:

Extensive Product Range: Offering over 700 Ayurvedic formulations catering to various health needs.

Buyer Due Diligence Brief — Evaluating Shree Baidyanath Ayurved Bhawan Pvt Ltd as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Baidyanath Ayurved has a commendable track record in the Ayurvedic pharmaceutical industry, with a history spanning over a century. The company's export volume and consistency are notable, with a total export value of $318,000 USD across 180 shipments, primarily in the Ayurvedic & Herbal Products category. Reliability indicators include adherence to GMP standards and a commitment to quality, ensuring the delivery of safe and effective products to international markets.

2Certifications to Verify

Importers should verify the following certifications when considering products from Baidyanath Ayurved:

FDA Registration: Confirm the company's registration status with the FDA for compliance with U.S. regulations.
WHO-GMP Certification: Ensure the manufacturing facilities are certified by the World Health Organization for Good Manufacturing Practices.
EU GMP Certification: Verify compliance with European Union Good Manufacturing Practices.

Frequently Asked Questions — Shree Baidyanath Ayurved Bhawan Pvt Ltd

How many pharmaceutical products does Shree Baidyanath Ayurved Bhawan Pvt Ltd export from India?

Shree Baidyanath Ayurved Bhawan Pvt Ltd exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Ayurvedic ($315.9K), Gutika ($2.0K). Total export value is $317.8K.

What is Shree Baidyanath Ayurved Bhawan Pvt Ltd's total pharmaceutical export value?

Shree Baidyanath Ayurved Bhawan Pvt Ltd's total pharmaceutical export value is $317.8K, based on 180 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Shree Baidyanath Ayurved Bhawan Pvt Ltd cover?

Shree Baidyanath Ayurved Bhawan Pvt Ltd exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Shree Baidyanath Ayurved Bhawan Pvt Ltd Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.